Buy YES Bank, prefer GAIL, Divis Labs: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "We are swing traders, so we are looking at only a short-term horizon. I think YES Bank's outperformance will continue. It is already breaking out to life time new highs again, so that is a buying opportunity. Remember short-term traders ideally go with momentum." "GAIL India had a two month consolidation, on Friday it broke out of that consolidation which also takes it to new highs for last six months and a breakout from a consolidation reach towards new highs for a ex period of time tells us there is more upside here. GAIL is one of the better performers in the Nifty, in the largecap universe and that should continue," he said. "Divis Laboratories has been an outperformer in the pharmaceutical sector. My preferred investment pick has been Dr Reddy’s Laboratories. It is a trading idea and Divis Laboratories as a trade seems to be appropriate in pharma."